Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL28146416 | 0.90 | USP2 (0.43) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| Propene SCHEMBL247056 | 0.87 | USP2 (0.47) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| Ethane SCHEMBL2303498 | 0.86 | USP2 (0.54) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| Methyl Alcohol SCHEMBL27869223 | 0.86 | USP2 (0.54) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| SCHEMBL1638881 | 0.86 | LMNA (0.53) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| SCHEMBL30754 | 0.86 | LMNA (0.53) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| Propene SCHEMBL8029718 | 0.85 | USP2 (0.45) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| Propene SCHEMBL10437872 | 0.85 | USP2 (0.45) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| Bicarbonate SCHEMBL29120397 | 0.84 | USP2 (0.41) | USP2KDM4ELMNAALDH1A1DUSP3 | |
| Propane SCHEMBL5154976 | 0.83 | USP2 (0.58) | USP2KDM4ELMNAALDH1A1DUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117925839-B | Biomarker for evaluating recurrence risk after treatment of multiple myeloma and application thereof | 南通大学附属医院 | 2025-04-01 | — | — | CN | disclosed |
| CN-118286135-A | Skin repair composition and application thereof in cosmetics | 上海枫萃生物科技有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-117925839-A | Biomarker for evaluating recurrence risk after treatment of multiple myeloma and application thereof | 南通大学附属医院 | 2024-04-26 | — | — | CN | disclosed |
| CN-117084953-A | Hair care or hair cleaning composition or skin care or skin cleaning composition | 魏德曼控股股份公司 | 2023-11-21 | — | — | CN | disclosed |
| CN-116919865-A | Dry mixture | 魏德曼控股股份公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-110505868-B | Personal care compositions | 魏德曼控股股份公司 | 2023-07-28 | — | — | CN | disclosed |
| EP-0734386-B1 | PLATELET ACTIVATING FACTOR ANTAGONISTS: IMIDAZOPYRIDINE INDOLES | ABBOTT LAB (US) | 2002-02-06 | — | — | EP | disclosed |
| EP-0821685-B1 | INDOLE-3-CARBONYL AND INDOLE-3-SULFONYL DERIVATIVES AS PLATELET ACTIVATING FACTOR ANTAGONISTS | ABBOTT LAB (US) | 2001-10-04 | — | — | EP | disclosed |
| EP-0595924-B1 | PLATELET ACTIVATING FACTOR ANTAGONISTS | ABBOTT LAB (US) | 1999-04-14 | — | — | EP | disclosed |
| EP-0821685-A1 | INDOLE-3-CARBONYL AND INDOLE-3-SULFONYL DERIVATIVES AS PLATELET ACTIVATING FACTOR ANTAGONISTS | ABBOTT LABORATORIES (US) | 1998-02-04 | — | — | EP | disclosed |
| WO-1992014732-A1 | INDOLES USEFUL AS PLATELET ACTIVATING FACTOR ANTAGONISTS | ABBOTT LABORATORIES (US) | 1992-09-03 | — | — | WO | disclosed |
| US-5144035-A | Chemical intermediates for platelet activating factor antagonists | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1992-09-01 | — | — | US | disclosed |
| EP-0499987-A1 | Platelet activating factor antagonists | ABBOTT LABORATORIES (US) | 1992-08-26 | — | — | EP | disclosed |
| US-5120751-A | Platelet activating factor antagonist | ABBOTT LABORATORIES (US) | 1992-06-09 | — | — | US | disclosed |
| US-5120749-A | Treatment of anaphylactic shock, respiratory distress syndrome, acute inflammation, delayed cellulosr immunity, parturtition, fetal lung maturation, and cellular differentiation | ABBOTT LABORATORIES (US) | 1992-06-09 | — | — | US | disclosed |
| EP-0425134-A1 | Condensed pyrrolo derivatives, process for their preparation and pharmaceutical compositions containing them | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1991-05-02 | — | — | EP | disclosed |
| US-4987132-A | PLATELET ACTIVATING FACTOR ANTAGONISTS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1991-01-22 | — | — | US | disclosed |
| US-4948795-A | PLATELET ACTIVATING FACTOR ANTAGONISTS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1990-08-14 | — | — | US | disclosed |
| EP-0350145-A2 | Pyridylthiazolidine carboxamide derivatives and their intermediates and production of both | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1990-01-10 | — | — | EP | disclosed |
| EP-0279681-A2 | Saturated heterocyclic carboxamide derivatives | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1988-08-24 | — | — | EP | disclosed |